Citations 18

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

EP Europace | January 5, 2018 | Volume: 20 | Issue: 1 | Pages: 157-208

10.1093/europace/eux275 | PMID 29016841

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators

Circulation | June 5, 2017 | Volume: 135 | Issue: 23 | Pages: 2310-2312

10.1161/circulationaha.117.027828 | PMID 28584032

Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis

Medical Science Monitor Basic Research | May 12, 2017 | Volume: 23 | Issue: No issue available | Pages: 179-222

10.12659/msmbr.903320 | PMID 28496093

Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review

Medical Science Monitor Basic Research | March 17, 2017 | Volume: 23 | Issue: No issue available | Pages: 58-86

10.12659/msmbr.902557 | PMID 28302997

Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation

JAMA Cardiology | December 14, 2016 | Volume: 2 | Issue: 3 | Pages: 319

10.1001/jamacardio.2016.4936 | PMID 28002833

HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials

Circulation | May 9, 2014 | Volume: 130 | Issue: 1 | Pages: 94-125

10.1161/cir.0000000000000056 | PMID 24815500

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators

Circulation | May 20, 2013 | Volume: 127 | Issue: 20 | Pages: 2021-2030

10.1161/circulationaha.112.000447 | PMID 23690453

Background— The risks of sports participation for implantable cardioverter-defibrillator (ICD) patients are unknown. Methods and Results— Athletes with ICDs (age, 10–60 years) participating in organized (n=328) or high-risk (n=44) sports were recruited. Sports-related and clinical data were obtained by phone interview and medical records. Follow-up occurred every 6 months. ICD shock data and clinical outcomes were adjudicated by 2 electrophysiologists. Median age was 33 years (89 subjects <20 years of age); 33% were female. Sixty were competitive athletes (varsity/junior varsity/traveling team). A pre-ICD history of ventricular arrhythmia was present in 42%. Running, basketball, and soccer were the most common sports. Over a median 31-month (interquartile range, 21–46 months) follow-up, there were no occurrences of either primary end point—death or resuscitated arrest or arrhythmia- or shock-related injury—during sports. There were 49 shocks in 37 participants (10% of study population) during competition/practice, 39 shocks in 29 participants (8%) during other physical activity, and 33 shocks in 24 participants (6%) at rest. In 8 ventricular arrhythmia episodes (device defined), multiple shocks were received: 1 at rest, 4 during competition/practice, and 3 during other physical activity. Ultimately, the ICD terminated all episodes. Freedom from lead malfunction was 97% at 5 years (from implantation) and 90% at 10 years. Conclusions— Many athletes with ICDs can engage in vigorous and competitive sports without physical injury or failure to terminate the arrhythmia despite the occurrence of both inappropriate and appropriate shocks. These data provide a basis for more informed physician and patient decision making in terms of sports participation for athletes with ICDs.
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

Europace | August 2, 2011 | Volume: 13 | Issue: 8 | Pages: 1077-1109

10.1093/europace/eur245 | PMID 21810866